1)Kohro T, Hayashi D, Okada Y, et al. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J. 2007; 71: 1835-40
|
|
|
2)Tanihata S, Nishigaki K, Kawasaki M, et al. Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1. Circ J. 2006; 70: 365-9
|
|
|
3)Fukunishi M, Nishigaki K, Okubo M, et al. J-SAP study 1-2: outcomes of patients with stable high-risk coronary artery disease receiving medical-preceding therapy in Japan. Circ J. 2006; 70: 1012-6
|
|
|
4)Hiro T, Kimura T, Morimoto T, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol. 2009; 54: 293-302
|
|
|
5)Suzuki T, Hosokawa H, Katoh O, et al. Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy: the result of Adjunctive Balloon Angioplasty After Coronary Atherectomy Study (ABACAS). J Am Coll Cardiol. 1999; 34: 1028-35
|
|
|
6)Tsuchikane E, Sumitsuji S, Awata N, et al. Final results of the STent versus directional coronary Atherectomy Randomized Trial (START). J Am Coll Cardiol. 1999; 34: 1050-7
|
|
|
7)Tsuchikane E, Suzuki T, Asakura Y, et al. Debulking of chronic coronary total occlusions with rotational or directional atherectomy before stenting: Final results of DOCTORS study. Int J Cardiol. 2008; 125: 397-403
|
|
|
8)Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119: 987-95
|
|
|
9)Kato M, Kimura T, Morimoto T, et al. Comparison of five-year outcome of sirolimus-eluting stent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher registry). Am J Cardiol. 2012; 110: 1282-9
|
|
|
10)Kimura T, Morimoto T, Nakagawa Y, et al. Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implanta-tion: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther. 2012; 27: 181-8
|
|
|
11)Nakao T, Kimura T, Morimoto T, et al. The long-term efficacy of cilostazol in addition to dual antiplatelet therapy after sirolimus-eluting stent implantation for Japanese patients: an analysis of the 3-year follow-up outcomes from the j-Cypher registry. Cardiovasc Interv Ther. 2012; 27: 161-7
|
|
|
12)Kishi K, Kimura T, Morimoto T, et al. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry. Circ Cardiovasc Interv. 2011; 4: 362-70
|
|
|
13)Tada T, Kimura T, Morimoto T, et al. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol. 2011; 107: 1155-62
|
|
|
14)Nakagawa Y, Kimura T, Morimoto T, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol. 2010; 106: 329-36
|
|
|
15)Abe M, Kimura T, Morimoto T, et al. Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry. Circulation. 2010; 122: 42-51
|
|
|
16)Shirai S, Kimura T, Nobuyoshi M, et al. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry. JACC Cardiovasc Interv. 2010; 3: 180-8
|
|
|
17)Toyofuku M, Kimura T, Morimoto T, et al. Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry. Circulation. 2009; 120: 1866-74
|
|
|
18)Kimura T, Morimoto T, Nakagawa Y, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. Circulation. 2012; 125: 584-91
|
|
|
19)Ikari Y, Kotani J, Kozuma K, et al. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). Circ J. 2009; 73: 1038-44
|
|
|
20)Nakamura M, Kotani J, Kozuma K, et al. Effectiveness of paclitaxel-eluting stents in complex clinical patients. Circ J. 2011; 75: 2573-80
|
|
|
21)Kimura T, Morimoto T, Natsuaki M, et al. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent trial (RESET). Circulation. 2012; 126: 1225-36
|
|
|
22)Kimura T, Morimoto T, Furukawa Y, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary interven-tion for multivessel coronary artery disease in the bare-metal stent era. Circulation. 2008; 118: S199-209
|
|
|
23)Tokushige A, Shiomi H, Morimoto T, et al. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv. 2012; 5: 237-46
|
|
|
24)Tada T, Natsuaki M, Morimoto T, et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 2012; 5: 381-91
|
|
|
25)Shiomi H, Morimoto T, Hayano M, et al. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2012; 110: 924-32
|
|
|
26)Natsuaki M, Nakagawa Y, Morimoto T, et al. Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2). Am J Cardiol. 2012; 109: 1387-96
|
|
|
27)Kohsaka S, Kimura T, Goto M, et al. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010; 105: 1698-704
|
|
|
28)Nakatani D, Sato H, Sakata Y, et al. Effect of intracoronary thrombectomy on 30-day mortality in patients with acute myocardial infarction. Am J Cardiol. 2007; 100: 1212-7
|
|
|
29)Kosuge M, Kimura K, Kojima S, et al. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J. 2006; 70: 217-21
|
|
|
30)Okura N, Ogawa H, Katoh J, Yamauchi T, Hagiwara N. Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry). Int J Cardiol. 2012; 156: 205
|
|
|
31)Ikari Y, Sakurada M, Kozuma K, et al. Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc Interv. 2008; 1: 424-31
|
|
|
32)Muramatsu T, Kozuma K, Tsukahara R, et al. Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial. Catheter Cardiovasc Interv. 2007; 70: 677-82
|
|
|
33)Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007; 370: 1483-93
|
|
|